News | Cardiovascular Ultrasound | June 16, 2017

Disparities Found in Standard of Cardiac Care for Heart Valve Disease in Minorities

heart valve regurgitation seen on an echocardiogram, cardiac ultrasound, from ASE study

June 15, 2017 – While much attention has been focused on ways to lower heart disease-related injuries and deaths, there is accumulating evidence that there is still much to be done for this work to reach all segments of the U.S. population. A group of researchers from Massachusetts General Hospital (MGH), looked at cardiovascular patient care during a 15-year time frame and found there remains significant disparities in routine cardiac care for chronic heart valve disease. Minorities, Hispanics in particular, continue to be less likely to receive timely and thorough cardiac ultrasound evaluations.  

Research led by Varsha K. Tanguturi, M.D., of MGH looked at more than 31,058 patient records and found that Hispanic patients were less likely to receive follow-up transthoracic echocardiograms (TTE) for their valve issues than would be considered appropriate by medical guidelines. 

“Looking at patient patterns from 2001-2016, our preliminary analysis shows there may be disparities in the receipt of surveillance imaging for mitral valve disease,” Tanguturi said. Researchers also found that as patients aged, the odds of having a TTE within the appropriate time interval decreased across all races.
Further research into other types of valvular disease in broader patient populations is needed to determine the extent and significance of these results. The cause of these disparities, whether from variability in ordering by the provider, or patient access to care is unknown. The clinical significance of these disparities is also yet to be determined, but identification of the causes could allow for interventions to improve the ability for at-risk patients to complete appropriate surveillance of valvular disease, which could in turn possibly improve cardiovascular health outcomes.   
Tanguturi will present a poster based on this research presented a poster based on this research during the recent American Society of Echocardiography (ASE) 2017 meeting. Additional researchers on the study “Disparities in Echocardiographic Surveillance of Mitral Regurgitation (MR),” include Vijeta Bhambhani, Michael Picard, M.D., Katrina Armstrong, M.D. and Jason Wasfy, M.D., MPhil.

Read the article "Race, Gender and Socioeconomic Factors Impact PCI Outcomes."

For more information:

Related Content

Sponsored Content | Videos | Cardiovascular Ultrasound| June 27, 2017
Partho Sengupta, M.D., professor of medicine, director of cardiovascular imaging and chair of cardiac innovations at
Mitralign Announces First European Subject Enrolled in SCOUT II Study of Trialign System
News | Heart Valve Technology| June 27, 2017
Mitralign Inc. announced the commencement of its SCOUT II study in Europe, with the Trialign System for the treatment...
GE Healthcare Vivid T8 cardiac ultrasound, highlights from the American Society of Echo ASE 2017
Feature | ASE| June 26, 2017
June 26, 2017 — Here is a list of some key clinical presentations and video interviews with cardiac ultrasound though
Sponsored Content | Videos | Business| June 23, 2017
Linda Gillam, M.D., MPH, FACC, FAHA, FASE, chair, cardiovascular medicine, Atlantic Health System, suggests how cardi
BioTrace Medical's Tempo Lead Shows Stability and Safety in Real-World Performance
News | Leads Implantable Devices| June 20, 2017
BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and...
BioImage-2 Study to Investigate Atherosclerotic Disease Progression
News | Cardiovascular Ultrasound| June 20, 2017
Mount Sinai Heart and BioImage-2 LLC recently announced the start of the BioImage-2 study investigating the progression...
Stroke2prevent Receives FDA 510(k) Clearance for A-View
Technology | Ultrasound Transesophageal echo (TEE)| June 20, 2017
June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S.
Bayer Arterion contrast Injector used to administer medical imaging contrast for CT scans.

Bayer Healthcare's Arterion contrast injector system.

Feature | Contrast Media| June 19, 2017 | Dave Fornell
Here are several updates in medical imaging...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 19, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiac ultrasound technologies at the Ameri
cardiac ultrasound echocardiography image from a GE E95 system at American society of echo to evaluate athlete's hearts and cardiac function
News | Cardiovascular Ultrasound| June 16, 2017
June 16, 2017 – Two research studies presented at the American Society of Echocardiography (ASE) 2017 scientific sess
Overlay Init